Boron Neutron Capture Therapy With B10 L-BPA for Unresectable Recurrent Head and Neck Cancers

PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 23, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

February 28, 2027

Conditions
Head and Neck CancerBoron Neutron Capture Therapy
Interventions
DRUG

Drug: B10 L-BPA Injection

"The investigational product is B10 L-BPA Injection, is a boron-containing compound in which 10B replaces a position on L-phenylalanine at the para position with dihydroxyboron.~This single arm of the study is designed to evaluate the therapeutic efficacy of BNCT, wherein patients receive B10 L-BPA administration followed by neutron irradiation."

Trial Locations (2)

Unknown

NOT_YET_RECRUITING

China Medical University Hospital, Taichung

RECRUITING

Taipei Veterans General Hsopital, Taipei,, Taipei

All Listed Sponsors
collaborator

Heron Neutron Medical Corp.

INDUSTRY

lead

China Medical University Hospital

OTHER

NCT06952868 - Boron Neutron Capture Therapy With B10 L-BPA for Unresectable Recurrent Head and Neck Cancers | Biotech Hunter | Biotech Hunter